# Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke

Study · id `cardio:ct-nct04491695` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04491695](<https://clinicaltrials.gov/study/NCT04491695>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04491695

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 420 participants.

## Technical summary

Registry record NCT04491695. Randomized; single masking; primary purpose treatment. Start 2020-09-12 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 420 participants (planned count; ClinicalTrials.gov record NCT04491695, source copy `cardio:ctgov-nct04491695-2022-07-19`, retrieved 2026-10-26)
- Started: 2020-09-12 (actual) (ClinicalTrials.gov record NCT04491695, source copy `cardio:ctgov-nct04491695-2022-07-19`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT04491695, source copy `cardio:ctgov-nct04491695-2022-07-19`, retrieved 2026-10-26)
- Completion: 2023-03-31 (anticipated) (ClinicalTrials.gov record NCT04491695, source copy `cardio:ctgov-nct04491695-2022-07-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04491695, source copy `cardio:ctgov-nct04491695-2022-07-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04491695-2022-07-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
- Acronym: TREND
- Condition: Acute Stroke
- Intervention (Drug): Tirofiban Hydrochloride
- Intervention (Drug): Oral antiplatelet
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Capital Medical University (`cardio:org-capital-medical-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial (`cardio:pubmed-38648030`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of tirofiban in preventing neurological deterioration in acute ischemic stroke with intracranial artery stenosis: A post hoc analysis of the TREND Trial (`cardio:pubmed-39950764`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Stroke etiology was associated with tirofiban efficacy in acute ischemic stroke without endovascular treatment: A pre-specified subgroup analysis of the TREND trial (`cardio:pubmed-40012523`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 997e47c5a7d0029477bb85de6295948561cad3148a6cd389e241f6edf926c952
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
